Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

anticancer/lafyèv

Lyen an sove nan clipboard la
Paj 1 soti nan 25 rezilta yo

Ferroelectric hyperthermia method for cancer treatment

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not applicable. FIELD OF THE INVENTION The invention relates to the treatment of tissue including cancerous tumors, and, more specifically, to systems and methods for implanting ferroelectric particles into tumorous tissue regions and

Cancer treatment by combining DNA molecules mimicking double strand breaks with hyperthermia

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
CROSS-REFERENCE TO RELATED APPLICATION This application is the U.S. national stage application of International Patent Application No. PCT/EP2012/059799, filed May 25, 2012. The Sequence Listing for this application is labeled "Seq-List-replace-2.txt" which was created on Jul. 10, 2015 and is 21 KB.

Hyperthermia and immunotherapy for leukemias lymphomas, and solid tumors

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND 1. Field of Invention This invention relates to hyperthermia and immunotherapy for treatment of cancer. BACKGROUND 2. Description of Prior Art The earliest references to treating cancer with hyperthermia can be found in Egyptian papyrus scrolls dated back to 3000 BC describing a breast

Hyperthermia and immunotherapy for cancer

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND 1. Field of Invention This invention relates to hyperthermia and immunotherapy for treatment of cancer. 2. Description of Prior Art The earliest references to treating cancer with hyperthernia can be found in Egyptian papyrus scrolls dated back to 3000 BC describing a breast cancer

Ferroelectric hyperthermia system and method for cancer therapy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
CROSS-REFERENCE TO RELATED APPLICATIONS Not applicable. STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not applicable. FIELD OF THE INVENTION The invention relates to the treatment of tissue including cancerous tumors, and, more specifically, to systems and methods for implanting

Pharmaceutical composition having antitumor activity

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
SUMMARY OF THE INVENTION The present invention relates to a pharmaceutical composition formed by an amide bonding between a highly pure antibody to tumour antigen and an antitumour substance. The first characteristic aspect of the present invention is to provide a pharmaceutical composition which

Compositions and methods for enhancing the effectiveness of systemic, HIPEC, IP, and related cancer treatments

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
INTRODUCTION Field of the Invention Aspects of the invention are directed to administration of a composition comprising one or more generally regarded as safe (GRAS) compounds selected from the group of components consisting of vitamins, selenium, fatty acids, fatty acid salts, and fatty acid

Compositions and methods for enhancing the effectiveness of systemic, HIPEC, IP, and related cancer treatments

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
INTRODUCTION Field of the Invention Aspects of the invention are directed to administration of a composition comprising one or more generally regarded as safe (GRAS) compounds selected from the group of components consisting of vitamins, selenium, fatty acids, fatty acid salts, and fatty acid

Pharmaceutical composition having antitumor activity

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
SUMMARY OF THE INVENTION The present invention relates to a pharmaceutical composition formed by an amide bonding between a highly pure antibody to tumor (especially, cancer) antigen and an antitumor substance (antineoplastic agent). The first characteristic aspect of the present invention is to

Radiofrequency-induced synchronization of in situ hyperthermia and chemotherapy via magnetic-nanoconjugates

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF INVENTION The present invention relates to a magnetic nanoparticle for tumor therapy, and particularly to a magnetic nanoparticle including an antibody and an anti-tumor drug, which achieves effective treatment of tumor therapy by synergistic effects between hyperthermia and targeted

Antineoplastic compositions

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND OF THE INVENTION 1. Field of The Invention The present invention relates to the use of selected chiral carbohydrates in cancer therapy and processes for their application. More particularly, the invention relates to the use of L-isomers of monosaccharides having cytotoxic and cytostatic

Antineoplastic compositions

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION The present invention relates to the use of selected chiral carbohydrates in cancer therapy and processes for their application. More particularly, the invention relates to the use of L-isomers of monosaccharides having cytotoxic and cytostatic properties. The selected

Method for selective expression of therapeutic genes by hyperthermia

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION The present invention generally relates to control of gene expression in tumor cells. Specifically, the present invention provides methods for using a heat inducible promoter operatively linked to a therapeutic gene to preferably induce both immune and anti-angiogenic
BACKGROUND OF THE INVENTION The invention relates generally to the use of sesquiterpene lactones in the treatment of infections caused by Flaviviridae and, more specifically, to the use of sesquiterpene lactone endoperoxides to treat hepatitis C infections, yellow fever, dengue fever, bovine viral
FIELD OF THE INVENTION The invention relates generally to the field of treatment of invasive agents, such as pathogens and cancers, in living organisms such as the human body and, more particularly, to a system that generates an energy field for application to the living organism, to activate
Antre nan paj
facebook nou an

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

  • Travay nan 55 lang
  • Geri èrbal te apiye nan syans
  • Remèd fèy rekonesans pa imaj
  • Kat entèaktif GPS - tag zèb sou kote (vini byento)
  • Li piblikasyon syantifik ki gen rapò ak rechèch ou an
  • Search remèd fèy medsin pa efè yo
  • Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

Google Play badgeApp Store badge